Tilak Healthcare, based in Paris, offers a promising solution in the health tech sector with its remote monitoring system for eye conditions. This system addresses issues like delayed detection and increased healthcare costs from relying solely on in-person ophthalmologist visits. By enabling patients to monitor their eye health remotely, Tilak facilitates early detection and treatment, potentially improving outcomes and reducing long-term costs. Supported by investors such as Elaia, iBionext, and Cap Horn, Tilak is well-positioned to carve out a niche in the ophthalmology market, making eye care more accessible and efficient.